Actinium Pharmaceuticals, Inc. (Delaware)

做多

ATNM - Potential bottom reversal

由swish30提供

Insiders bought recently before the offering at $1.10 per share. Slightly risky when Actimab-A Phase 2 results could come out anytime.

更多:

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。